A function approximation approach to the prediction of blood glucose levels
H.N. Mhaskar, S.V. Pereverzyev, M.D. van der Walt

TL;DR
This paper presents a novel function approximation method for real-time blood glucose level prediction using continuous glucose monitoring data, outperforming standard deep networks especially during abnormal glucose regimes.
Contribution
The paper introduces a new supervised function approximation approach leveraging manifold learning concepts for blood glucose prediction, handling distribution shifts between training and testing data.
Findings
Outperforms standard deep networks in hypoglycemic and hyperglycemic regimes.
Uses the PRED-EGA grid for clinically relevant evaluation.
Handles training and test data from different distributions.
Abstract
The problem of real time prediction of blood glucose (BG) levels based on the readings from a continuous glucose monitoring (CGM) device is a problem of great importance in diabetes care, and therefore, has attracted a lot of research in recent years, especially based on machine learning. An accurate prediction with a 30, 60, or 90 minute prediction horizon has the potential of saving millions of dollars in emergency care costs. In this paper, we treat the problem as one of function approximation, where the value of the BG level at time (where the prediction horizon) is considered to be an unknown function of readings prior to the time . This unknown function may be supported in particular on some unknown submanifold of the -dimensional Euclidean space. While manifold learning is classically done in a semi-supervised setting, where the entire data has to be known in…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsDiabetes Management and Research · Hyperglycemia and glycemic control in critically ill and hospitalized patients · Diabetes, Cardiovascular Risks, and Lipoproteins
